NovaBay Pharmaceuticals, Inc. (NBY)

4.68 +0.11 (+2.41%) USD  |  NYAM  |  Dec 24, 12:59
4.75 +0.07 (+1.50%) After-Hours: 13:51
More

NovaBay Pharmaceuticals SG&A Expense (TTM): 8.584M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Cassava Sciences, Inc. 68.06M
cbdMD, Inc. 14.13M
Palatin Technologies, Inc. 7.449M
Theriva Biologics, Inc. 16.21M
Oragenics, Inc. 6.832M